Private Equity Liquidity Events
BDR Pharma buys majority stake in oral care biz of Acme Formulation at Rs.2,370-Cr valuation
Source Acme Formulation's (opens in a new tab)Business Line (opens in a new tab)
Mumbai-based BDR Pharma will acquire a controlling stake in Solan, Himachal Pradesh-headquartered Acme Formulation's oral solid formulations business and its subsidiaries from its existing shareholders, led by PAG. The transaction values the business at about INR 2,370 crore (USD 250 million). o3 Capital acted as the exclusive financial advisor to BDR Pharma on the transaction.Post the deal, PAG and BDR’s promoters will retain ownership of Immacule, a sterile injectable-focused contract manufacturing businesses.
In Jul 2021, Acme Formulation had attracted about $ 145 M from Pacific Alliance Group.For FY25, Acme Formulation had reported about INR 210 Cr in Operating Income and about INR 32 Cr in PAT.